- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Mineweb reported that yesterday, Moody’s Investors Service downgraded Molycorp Inc.’s (NYSE:MCP) corporate family rating (CFR) from Caa1 to Caa2.
Mineweb reported that yesterday, Moody’s Investors Service downgraded Molycorp Inc.’s (NYSE:MCP) corporate family rating (CFR) from Caa1 to Caa2. The firm cited “continued weakness in rare earths pricing environment, ongoing negative free cash flows, weak liquidity and high leverage” as its reason for doing so.
As quoted in the market news:
‘Although Molycorp has now completed the construction of its Mountain Pass production facility and faces significantly lower capex requirements going forward, the project’s cost overruns left the company with absolute debt levels that may be unsustainable in a current price environment,’ said Moody’s Vice President and Senior Analyst, Anna Zubets-Anderson and Managing Director for Corporate Finance Brian B. Oak.
Molycorp’s total debt as of March 31, 2014, was US$1.14 billion with interest expense for the preceding 12 months at $140 million. At the same time, the company’s EBITDA and operating cash flows ‘were substantially negative’ for the same 12 months ended March 31, 2014, amounting to negative $140 million and $210 million respectively.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.